Role of a 49 kDa Trypanosoma cruzi Mucin-Associated Surface Protein (MASP49) during the Infection Process and Identification of a Mammalian Cell Surface Receptor

An algorithm for annotation and classification of T. cruzi MASP sequences: towards a better understanding of the parasite genetic variability

BACKGROUND

Trypanosoma cruzi, the protozoan causing Chagas disease, is responsible for a neglected tropical disease affecting millions in Latin America. Its genome contains rapidly evolving multigene families, such as mucins (TcMUC), trans-sialidases (TS), and mucin-associated surface proteins (MASP), which are essential for parasite transmission and disease mechanisms. However, methodological challenges in genome assembly and annotation have limited the characterization of these gene families, particularly MASPs.

RESULTS

We developed a bioinformatic pipeline for the automatic identification, characterization, and annotation of MASPs directly from T. cruzi genome assemblies. This algorithm, based on a manually curated MASP database and HMM-based identification of MASP diagnostic motifs, enables the robust classification of these molecules into canonical MASPs, MASP-related molecules (mostly pseudogenes), and chimeric sequences combining MASPs and TcMUC/TS genes. Validation against a rigorously annotated dataset demonstrated high accuracy, and allowed us to reclassify misanotated sequences and, more crucially, to accurately identify previously unrecognized canonical MASPs and MASP chimeras. This algorithm was then used to explore the MASP repertoire in the genomes of 13 parasite strains from different evolutionary lineages, revealing patterns of diversity. For instance, TcI and TcII strains exhibited higher ratios of canonical MASP/MASP-related molecules and a greater abundance of MASP chimeras, suggesting that their genomes are under strong selective pressures towards maintaining a broader panel of full-length MASP genes at the expense of pseudogenes. On the contrary, structural features of canonical MASPs, MASP-related sequences, and MASP-chimeras were largely conserved across parasite genomes.

CONCLUSIONS

This novel pipeline automates the annotation of MASPs, a key surface protein family unique to T. cruzi, improving genome annotation and enabling robust comparative analyses. It provides an essential tool for exploring the evolutionary dynamics of multigene families in T. cruzi and could be extended to other gene families.

Trypanosoma cruzi: Genomic Diversity and Structure

Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease, and one of the most important parasitic diseases worldwide. The first genome of T. cruzi was sequenced in 2005, and its complexity made assembly and annotation challenging. Nowadays, new sequencing methods have improved some strains' genome sequence and annotation, revealing this parasite's extensive genetic diversity and complexity. In this review, we examine the genetic diversity, the genomic structure, and the principal multi-gene families involved in the pathogenicity of T. cruzi. The T. cruzi genome sequence is divided into two compartments: the core (conserved) and the disruptive (variable in length and multicopy gene families among strains). The disruptive region has also been described as genome plasticity and plays a key role in the parasite survival and infection process. This region comprises several multi-gene families, including trans-sialidases, mucins, and mucin-associated surface proteins (MASPs). Trans-sialidases are the most prevalent genes in the genome with a key role in the infection process, while mucins and MASPs are also significant glycosylated proteins expressed on the parasite surface, essential for its biological functions, as host-parasite interaction, host cell invasion or protection against the host immune system, in both insect and mammalian stages. Collectively, in this review, some of the most recent advances in the structure and composition of the T. cruzi genome are reviewed.

The End Justifies the Means: Chagas Disease from a Perspective of the Host-Trypanosoma cruzi Interaction

The neglected Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi. Despite CD dispersion throughout the world, it prevails in tropical areas affecting mainly poor communities, causing devastating health, social and economic consequences. Clinically, CD is marked by a mildly symptomatic acute phase, and a chronic phase characterized by cardiac and/or digestive complications. Current treatment for CD relies on medications with strong side effects and reduced effectiveness. The complex interaction between the parasite and the host outlines the etiology and progression of CD. The unique characteristics and high adaptability of T. cruzi, its mechanisms of persistence, and evasion of the immune system seem to influence the course of the disease. Despite the efforts to uncover the pathology of CD, there are many gaps in understanding how it is established and reaches chronicity. Also, the lack of effective treatments and protective vaccines constitute challenges for public health. Here, we explain the background in which CD is established, from the peculiarities of T. cruzi molecular biology to the development of the host's immune response leading to the pathophysiology of CD. We also discuss the state of the art of treatments for CD and current challenges in basic and applied science.